ABSTRACT-We examined the effects of IV°-nitro-L-arginine (L-NNA) on isolated rabbit afferent arterioles to confirm that nitric oxide is released at the resistance vessel level in the kidney. We microdissected the superficial afferent arterioles from the kidneys of New Zealand White rabbits. Each afferent arteriole was cannulated with a micropipette system, and the intraluminal pressure was set at 80 mmHg. By our methods, we found that norepinephrine (NE) decreased the lumen diameter of the afferent arterioles in a dose-depend ent manner, and acetylcholine increased the lumen diameter of NE-constricted afferent arterioles. L-NNA (10-4 M) gradually decreased the lumen diameter of afferent arterioles from 21.5±0.9 to 18.6±0.9 pm in 20 min, but 1V°-nitro-D-arginine (10-4 M) did not affect them (from 21.8 ± 1.3 to 21.8 ± 1.5 pm). L-Arginine (10-2 M) restored the lumen diameter of L-NNA-contracted afferent arterioles to the control levels. These findings indicate that the isolated afferent arteriole has the ability to release or to synthesize and release nitric oxide under basal conditions and that this basal release of nitric oxide plays an important role in the basal tone of the afferent arteriole.
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In 1980, Furchgott and Zawadzki (1) reported the ex istence of endothelium-derived relaxing factor (EDRF). Subsequent studies (2 4) have shown that EDRF activity is due to the release of nitric oxide (NO), which originates from the terminal guanidino nitrogen atom of the amino acid L-arginine. Moreover, NO synthase (NOS) inhibitors have been developed (5-7). These inhibitors make it possible for us to evaluate the physiological role of EDRF/NO in regulating systemic hemodynamics and organ hemodynamics.
Recently, we reported that NO plays an important role in renal hemodynamics and function in pentobarbital anesthetized dogs (8) . Other researchers have also report ed that NO is an important factor in the regulation of renal hemodynamics and urine formation (9-15). However, there are few reports evaluating the importance of NO in the regulation of renal hemodynamics at the resistance vessel level. Moreover, NO seems to be generat ed not only in the vascular endothelium but also in other cells such as vascular smooth muscle (16) , peripheral nerve (17) , mesangium (18) and macula densa cell (19) . Thus, the renal effects of NOS inhibitors may not be sole ly due to a decrease in the release and/or production of en dothelial NO. We are also interested in knowing whether or not NO is produced at the resistance vessel level in the kidney as well as in the large arteries, because arterioles and capillaries were reported to display very little NOS by the use of immunohistochemical techniques (20) . Kon et al. (21) suggested that EDRF may be mainly produced by the main renal artery and may then be distributed to the resistance vessels in the rat kidney.
The present study was designed to examine the ability of the afferent arteriole to release NO and evaluate the im portance of NO in regulating vascular tone at the afferent arteriole. We examined the effects of 1V°-nitro-L-arginine (L-NNA), a NO synthesis inhibitor, and L-arginine on iso lated rabbit afferent arterioles without glomeruli.
MATERIALS AND METHODS
Adult male New Zealand White rabbits (2.0-2.5 kg) maintained on standard rabbit chow, were anesthetized with intravenous sodium pentobarbital (25 mg/kg), fol lowed by a maintenance dose when necessary. The kidney was exposed through a retroperitoneal flank incision, and the renal pedicle was clamped and cut. The kidney was quickly removed and placed in iced modified Krebs-Rin ger solution. The renal artery was catheterized with PE 50 tubing, and the kidney was flushed with chilled modified Krebs-Ringer solution to remove the cell components from the blood. The kidney was then perfused with an isosmotic Krebs-Ringer solution containing human albu min (Green Cross, Osaka), dextran blue 2,000 (Pharma cia Fine Chemical, Uppsala, Sweden), and indocyanine green (Daiichi Seiyaku, Tokyo) (22) . This dye solution en abled us to easily distinguish the afferent arteriole. Thin slices were cut and transferred to a dish containing chilled modified Krebs-Ringer solution. The dissection solution was a modified Krebs-Ringer (pH 7.4) consisting of 105 mM NaCl, 5 mM KC1, 25 mM NaHCO3, 2.3 mM Na2HPO4, 10 mM Na acetate, 1 MM MgSO4, 2 mM CaC12, 8.3 mM glucose, 5 mM alanine, 0.01 mM EDTA, and 10 mM HEPES. The superficial afferent arteriole was dissect ed free from the surrounding tissue and all tubular frag ments were removed under a stereoscopic microscope (SZH, Olympus, Tokyo) using thin steel needles and shar pened forceps (No. 5, Dumont, Basel, Switzerland); all procedures were performed at 41C (23) . Great care was taken to avoid touching the vessels and to avoid exerting longitudinal or transverse tension on them. The arteriole was transferred to a temperature-regulated chamber (ITM, San Antonio, TX, USA) mounted on the stage of an inverted microscope (Diaphot, Nikon, Tokyo). The volume of the chamber was 1 ml. Fresh bath medium was supplied to the bottom right side of the chamber at 0.5 ml/min, while the medium in the chamber was drained by gently sucking it out of the top of the left side of the cham ber. The bath medium was a modified Krebs-Ringer solu tion identical to the dissection solution, bubbled with 95 010 02 and 5 % CO2. During the experiment, water-satu rated gas (90010 02 and 10% C02) was gently blown over the surface of the bath to maintain the pH at 7.4. The schematic illustration of a cannulated vessel is shown in Fig. 1 . The micropipette system is similar to that of Duling et al. (24) and Edwards (25) . The method of cannulating the afferent arteriole into the micropipette sys tem is similar to that reported by Osgood et al. (22) and Ito and Carretero (26) . One end of the afferent arteriole was drawn into the "A" holding pipette, which had a con striction (internal diameter, about 20 gm). The tip of the "B" perfusion pipette (internal diameter, about 10 rim) was advanced into the lumen of the afferent arteriole. A stronger vacuum was then applied to the "A" holding pipette to pull the afferent arteriole further toward the constriction in the "A" holding pipette and thereby seal it between the two pipettes. The afferent arteriole was per fused with the modified Krebs-Ringer containing 1010 of bovine serum albumin to remove the dye solution and blood components. After perfusion of the afferent arteri ole was stopped, the other end of the afferent arteriole was captured and sealed in the "D" pipette that had a larger constriction (internal diameter, about 5 pm). After completion of cannulation, the intraluminal pressure was controlled with a screw driven syringe and set at 80 mmHg (Fig. 2) . The intraluminal pressure was continu ously monitored with a pressure transducer and monitor (Digic VPC, Valcom, Tokyo). Major leaks of fluid could be seen because of the different refractile properties of the perfusate and bath solution. If the intraluminal pressure could not be maintained at a constant level, the experi ment was discarded. After the pressure was set, the pipettes were adjusted so that all bends in the vessel were removed. Microdissection and cannulation of the afferent arteriole were completed within 90 min at 41C. The tem perature of the bath was gradually raised to 371C and monitored during the experiment (E5CS, Omron, Kyoto). A 30-min equilibration period was allowed before each ex periment. The image of the afferent arteriole was record ed with a video system, consisting of a CCD camera with a control unit and camera adaptor (CCD-10, Olympus), monitor (NV-0930Z, Mitsubishi, Tokyo) and video recorder (TIMELAPSE BR-9000, JVC, Tokyo). The lumen diameter of the afferent arteriole was measured directly on the video monitor screen at 3 to 5 points. Repeat measurements were made at these same points. Data represented are mean values of the lumen diameter of 3 to 5 points. At the end of the experiment, the viabil ity of the vessel was assessed by the response to 10-6 M norepinephrine (NE).
Experimental protocols
Responses to NE: Following a 30-min equilibration, control measurements of lumen diameter were made at 1 min intervals for 3 min. The control value is the mean value of three measurements. During the control measure ments, we confirmed that the lumen diameter was stable. If the lumen diameter was not stable during the control observation, the experiment was discarded. After the control measurements, continuous bath exchange was stopped, and NE was applied cumulatively at 2-min inter vals. A 100-pl aliquot of oxygenated bath medium con taining NE was gently applied from the right side of the chamber, and drainage of bath medium was continued from the left side of the chamber. The lumen diameter was measured 1 min after application of each concentra tion of the drug.
Responses to acetylcholine (ACh): After the control measurements, vessel tone of the afferent arteriole was in duced by NE (mean concentration of NE was 2.7 x 10-7 M). The concentration of NE used to induce vessel tone varied, but the concentration decreased the lumen diam eter by about 30°70. After we confirmed the stable lumen diameter, ACh was applied to the bath cumulatively at 2-min intervals, and lumen diameter was measured 1 min after the application.
Effects of L-NNA on isolated afferent arterioles: After the control measurements, the infusion of bath medium containing L-NNA (10-4 M) was initiated at 0.5 ml/min, and the arteriole was observed for 60 min. These experi ments showed that L-NNA decreased the lumen diameter of the afferent arterioles, and the effect of L-NNA reached maximum at 20 min after the start of L-NNA. Thus, we evaluated the effects of L-NNA after 20 min. The effect of N'-nitro-D-arginine (D-NNA) on the affer ent arterioles was also evaluated by the same method.
Effect of L-arginine on the lumen diameter of the affer ent arterioles pretreated with L-NNA: L-Arginine is reported to be a substrate of EDRF (7), and L-NNA is be lieved to be an inhibitor of NO synthase (5, 27) . We exam ined the effects of L-arginine on the L-NNA-constricted afferent arterioles. After a 20-min application of L-NNA (10-4 M), the bath medium was changed to a medium con taining L-NNA (10-'M) and L-arginine (10-'M).
Chemicals
A"-nitro-L-arginine, AlG-nitro-D-arginine, L-arginine and D-arginine were purchased from the Peptide Institute (Osaka). Bovine albumin fraction V was purchased from Seikagaku Kogyo Co., Ltd. (Tokyo).
Statistics
Values are expressed as the mean±S.E.M. The data were analyzed with a two-way analysis of variance with completed randomized block. The significance of differ ences were determined by the least significance test (28). 
RESULTS
Responses to NE Figure 3 shows an example of the afferent arteriolar response to NE. Because NE at 10-6 M constricted the en tire afferent arteriole, we could not observe the lumen diameter. The dose-response curves of NE on the lumen diameter of afferent arterioles are shown in Fig. 4 (upper   panel) . The lumen diameter of the afferent arterioles un der control conditions was 21.8 ± 1.0 pm (n=9). NE decreased the lumen diameter of afferent arterioles in a dose-dependent manner.
Responses to ACh
The dose-response curves of ACh on the lumen diam eter of afferent arterioles are shown in Fig. 4 (lower   panel) . Before we applied ACh, the afferent arteriole was partially constricted with NE (mean concentration of NE was 2.7 x 10-7 M). The lumen diameter of the afferent arteriole decreased from 21.8± 1.0 to 15.4± 1.0 pm with NE (n = 9). ACh increased the lumen diameter of NE-con stricted afferent arterioles. (Fig. 6) .
Effect of L-arginine on the lumen diameter of the afferent arterioles pretreated with L-NNA A 20-min application of L-NNA (10-4 M) also decreased the lumen diameter of afferent arterioles from 21.9±1.3 to 16.9 ± 0.9 pm (n=6). A 20-min application of L-arginine (10-2 M) restored the lumen diameter of L NNA-contracted afferent arterioles to the control value (from 16.9±0.9 to 20.5± 1.5 pm, n=6) (Fig. 7) . D-Argi nine (10-2 M) did not increase the lumen diameter of L NNA-constricted afferent arterioles (data not shown). 
DISCUSSION
Many experiments using large vessels have provided substantial information about the mechanisms of vasoac tive substances. However, organ circulation is mainly regulated at the resistance vessel level, not at the large ves sel level. Recent technological developments have enabled us to directly assess renal microcirculation (29, 30) . Our method is modified from Edwards' method (25) and en ables us to evaluate the direct actions of vasoactive sub stances on the arterioles. With our methods, we found that NE decreased the lumen diameter of afferent arteri oles in a dose-dependent manner, and ACh increased the lumen diameter of NE-constricted afferent arterioles. These results indicate that our method can be used to evaluate the effects of vasoactive substances at the resistance vessel level.
Since Furchgott and Zawadzki (1) proposed the func tion of EDRF in 1980, evidence that EDRF plays a role in the regulation of renal circulation has been accumulated. We have previously reported that an intrarenal infusion of L-NNA decreased renal blood flow (RBF) and L-argi nine increased RBF in pentobarbital anesthetized dogs (8) . The blockade of NOS with several inhibitors has been reported to decrease RBF under several experimental con ditions (9, (11) (12) (13) (14) 31) . These results suggest that NO plays an important role in regulating renal hemodynam ics. However, there are few reports that evaluate the role of EDRF in the renal resistance vessels (23, 32) , and it is still a question whether NO is produced and released in the resistance vessels. Immunohistochemical studies have indicated that the NOS of the endothelial layers is local ized mainly in large vessels, not in arterioles and capilla ries (20) . Kon et al. (21) reported that EDRF, which is primarily produced by the main renal artery, acts as a vasodilator at resistance arterioles in Munich-Wistar rats.
In this study, we determined whether EDRF/NO is produced and released at the resistance vessel level of the kidney with isolated rabbit afferent arterioles. L-NNA decreased the lumen diameter of afferent arterioles, but D-NNA did not affect them. Moreover, L-arginine reversed the lumen diameter of L-NNA-contracted affer ent arterioles to control values. Ito et al. (23, 32) have al ready reported that L-NNA decreased the basal diameter of the isolated microperfused rabbit afferent arterioles with glomerulus by 15% or 18%. In preliminary experi ments, Hoffend et al. (33) reported that 1V~-nitro-L-argi nine methyl ester decreased the diameter of efferent arteri oles but did not affect that of afferent arterioles in the split hydronephrotic kidney of rats. Our results are consistent with Ito's reports. However, Mundel et al. (19) recently reported that macula densa cells may produce consider able amounts of NO. The microdissected afferent arteri ole with the glomerulus may contain a portion of macula densa cells (34) . Thus, we cannot rule out the influence of NO produced in the macula densa cells when evaluating the results of experiments using microdissected afferent arteriole with the glomerulus. To avoid this difficulty, we microdissected only the afferent arteriole without the glomerulus and tubule from the kidney of New Zealand White rabbit. Our findings indicate that the isolated affer ent arteriole has the ability to release or to synthesize and release NO under basal conditions and this basal release of NO plays a significant role in the basal tone of the affer ent arteriole.
At least three types of NOS, endothelial NOS, neuronal NOS and macrophage NOS, have been identified (20) . In endothelial cells and neuronal tissue, NOS is cal cium/calmodulin-dependent, and its enzymatic activity is constitutively expressed. However, macrophage NOS is independent of calcium/calmodulin, and its enzymatic activity is induced by lipopolysaccharide and r-interferon over a period of many hours (20, 35) . In the kidney, NO may be synthesized not only in the vascular endothelium but also in other cells such as macrophages (36) , vascular smooth muscle (16) , peripheral nerve (17), mesangium (18) and macula densa cells (19) . In this experiment, we used only isolated afferent arteriole without the glomeru lus. Thus, we can rule out the NO that originates from mesangium and macula densa cell. Our acute experiment suggests that the basal release of NO from isolated affer ent arterioles may be derived from the cells having con stitutive NOS. In our preparation, the endothelium and nerve fibers may be the candidates for the NO-releasing cells. The origin of NO remains unclear in our experiment because endothelial denudation is difficult in microvascu lar studies.
In summary, the microdissected afferent arteriole of New Zealand White rabbit has the ability to release or to synthesize and release NO, and the basal release of NO plays a significant role in the basal tone of the afferent arteriole.
